Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 24;40(1):e37.
doi: 10.1017/S026646232400059X.

Health technology assessment and innovation: here to help or hinder?

Linda Mundy  1 , Ben Forrest  2 , Li-Ying Huang  3 , Guy Maddern  4
Affiliations
Review

Health technology assessment and innovation: here to help or hinder?

Linda Mundy et al. Int J Technol Assess Health Care. .

Abstract

Innovative health technologies offer much to patients, clinicians, and health systems. Policy makers can, however, be slow to embrace innovation for many reasons, including a less robust body of evidence, perceived high costs, and a fear that once technologies enter the health system, they will be difficult to remove. Health technology funding decisions are usually made after a rigorous health technology assessment (HTA) process, including a cost analysis. However, by focusing on therapeutic value and cost-savings, the traditional HTA framework often fails to capture innovation in the assessment process. How HTA defines, evaluates, and values innovation is currently inconsistent, and it is generally agreed that by explicitly defining innovation would recognize and reward and, in turn, stimulate, encourage, and incentivize future innovation in the system. To foster innovation in health technology, policy needs to be innovative and utilize other HTA tools to inform decision making including horizon scanning, multicriteria decision analysis, and funding mechanisms such as managed agreements and coverage with evidence development. When properly supported and incentivized, and by shifting the focus from cost to investment, innovation in health technology such as genomics, point-of-care testing, and digital health may deliver better patient outcomes. Industry and agency members of the Health Technology Assessment International Asia Policy Forum (APF) met in Taiwan in November 2023 to discuss the potential of HTA to foster innovation, especially in the Asia region. Discussions and presentations during the 2023 APF were informed by a background paper, which forms the basis of this paper.

Keywords: Asia; decision making; diffusion of innovation; health; health care evaluation mechanisms; health policy; health services needs and demand; technology assessment.

PubMed Disclaimer

Conflict of interest statement

The authors declare none.

Figures

Figure 1.
Figure 1.
clouds generated by APF delegates, defining innovation on Day 1 (A) and Day 3 (B). APF, Asia Policy Forum.
See this image and copyright information in PMC

References

    1. Mundy L. Being bold – How HTA can foster innovation in the Asia region: HTAi Asia Policy Forum background paper [Internet] [cited 14 January 2024]. 2023. Available from: https://htai.org/wp-content/uploads/2023/11/APF-2023-Background-paper_FI....
    1. O’Rourke B, Oortwijn W, Schuller T. The new definition of health technology assessment: A milestone in international collaboration. Int J Technol Assess Health Care. 2020;36:187–190. - PubMed
    1. Charlton V, Rid A. Innovation as a value in healthcare priority-setting: The UK experience. Soc Justice Res. 2019;32:208–238. - PMC - PubMed
    1. Chan MS, Kowalik JC, Ashfield T, Pearson-Stuttard J. Improving health evaluations to capture wider value of therapeutics and incentivise innovation. Front Public Health. 2023;11:e1119652. - PMC - PubMed
    1. de Solà-Morales O, Cunningham D, Flume M, et al. Defining innovation with respect to new medicines: A systematic review from a payer perspective. Int J Technol Assess Health Care. 2018;34:224–240. - PubMed

LinkOut - more resources